ID   M3K7_HUMAN              Reviewed;         606 AA.
AC   O43318; B2RE27; O43317; O43319; Q5TDN2; Q5TDN3; Q5TDT7;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   05-OCT-2010, entry version 118.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase 7;
DE            EC=2.7.11.25;
DE   AltName: Full=Transforming growth factor-beta-activated kinase 1;
DE            Short=TGF-beta-activated kinase 1;
GN   Name=MAP3K7; Synonyms=TAK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1A; 1B AND 1C).
RC   TISSUE=Lung;
RX   MEDLINE=98153801; PubMed=9480845; DOI=10.1006/bbrc.1998.8124;
RA   Sakurai H., Shigemori N., Hasegawa K., Sugita T.;
RT   "TGF-beta-activated kinase 1 stimulates NF-kappa B activation by an
RT   NF-kappa B-inducing kinase-independent mechanism.";
RL   Biochem. Biophys. Res. Commun. 243:545-549(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1A).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1A).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH TAB1.
RX   MEDLINE=96216294; PubMed=8638164; DOI=10.1126/science.272.5265.1179;
RA   Shibuya H., Yamaguchi K., Shirakabe K., Tonegawa A., Gotoh Y.,
RA   Ueno N., Irie K., Nishida E., Matsumoto K.;
RT   "TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal
RT   transduction.";
RL   Science 272:1179-1182(1996).
RN   [8]
RP   INTERACTION WITH TRAF6 AND TAB1.
RX   PubMed=10094049; DOI=10.1038/18465;
RA   Ninomiya-Tsuji J., Kishimoto K., Hiyama A., Inoue J., Cao Z.,
RA   Matsumoto K.;
RT   "The kinase TAK1 can activate the NIK-I kappaB as well as the MAP
RT   kinase cascade in the IL-1 signalling pathway.";
RL   Nature 398:252-256(1999).
RN   [9]
RP   INTERACTION WITH TAB1, PHOSPHORYLATION AT THR-184; THR-187 AND
RP   SER-192, AND ACTIVATION.
RX   PubMed=10838074; DOI=10.1016/S0014-5793(00)01588-X;
RA   Sakurai H., Miyoshi H., Mizukami J., Sugita T.;
RT   "Phosphorylation-dependent activation of TAK1 mitogen-activated
RT   protein kinase kinase kinase by TAB1.";
RL   FEBS Lett. 474:141-145(2000).
RN   [10]
RP   UBIQUITINATION, FUNCTION, ENZYME REGULATION, INTERACTION WITH TAB1 AND
RP   TAB2, AND IDENTIFICATION IN THE TRIKA2 COMPLEX.
RX   PubMed=11460167; DOI=10.1038/35085597;
RA   Wang C., Deng L., Hong M., Akkaraju G.R., Inoue J., Chen Z.J.;
RT   "TAK1 is a ubiquitin-dependent kinase of MKK and IKK.";
RL   Nature 412:346-351(2001).
RN   [11]
RP   INTERACTION WITH PELI1 AND PELI2.
RX   MEDLINE=22689054; PubMed=12804775; DOI=10.1016/S0014-5793(03)00533-7;
RA   Jensen L.E., Whitehead A.S.;
RT   "Pellino2 activates the mitogen activated protein kinase pathway.";
RL   FEBS Lett. 545:199-202(2003).
RN   [12]
RP   INTERACTION WITH PELI3.
RX   MEDLINE=22756745; PubMed=12874243;
RA   Jensen L.E., Whitehead A.S.;
RT   "Pellino3, a novel member of the Pellino protein family, promotes
RT   activation of c-Jun and Elk-1 and may act as a scaffolding protein.";
RL   J. Immunol. 171:1500-1506(2003).
RN   [13]
RP   FUNCTION, INTERACTION WITH SMAD7; MAP2K3 AND P38 KINASE, AND
RP   MUTAGENESIS OF LYS-63.
RX   MEDLINE=22477345; PubMed=12589052; DOI=10.1091/mbc.02-03-0037;
RA   Edlund S., Bu S., Schuster N., Aspenstroem P., Heuchel R.,
RA   Heldin N.E., ten Dijke P., Heldin C.H., Landstrom M.;
RT   "Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of
RT   prostate cancer cells involves Smad7-dependent activation of p38 by
RT   TGF-beta-activated kinase 1 and mitogen-activated protein kinase
RT   kinase 3.";
RL   Mol. Biol. Cell 14:529-544(2003).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-439, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [15]
RP   UBIQUITINATION, PHOSPHORYLATION AT THR-187 BY AUTOCATALYSIS, SUBUNIT,
RP   AND FUNCTION.
RX   PubMed=16845370; DOI=10.1038/sj.embor.7400754;
RA   Thiefes A., Wolf A., Doerrie A., Grassl G.A., Matsumoto K.,
RA   Autenrieth I., Bohn E., Sakurai H., Niedenthal R., Resch K.,
RA   Kracht M.;
RT   "The Yersinia enterocolitica effector YopP inhibits host cell
RT   signalling by inactivating the protein kinase TAK1 in the IL-1
RT   signalling pathway.";
RL   EMBO Rep. 7:838-844(2006).
RN   [16]
RP   FUNCTION, ENZYME REGULATION, AND INTERACTION WITH TAOK1 AND TAOK2.
RX   PubMed=16893890; DOI=10.1074/jbc.M603627200;
RA   Huangfu W.C., Omori E., Akira S., Matsumoto K., Ninomiya-Tsuji J.;
RT   "Osmotic stress activates the TAK1-JNK pathway while blocking TAK1-
RT   mediated NF-kappaB activation: TAO2 regulates TAK1 pathways.";
RL   J. Biol. Chem. 281:28802-28810(2006).
RN   [17]
RP   INTERACTION WITH PP2A AND PPP6C, AND DEPHOSPHORYLATION AT THR-187 BY
RP   PP2A AND PPP6C.
RX   PubMed=17079228; DOI=10.1074/jbc.M608155200;
RA   Kajino T., Ren H., Iemura S., Natsume T., Stefansson B.,
RA   Brautigan D.L., Matsumoto K., Ninomiya-Tsuji J.;
RT   "Protein phosphatase 6 down-regulates TAK1 kinase activation in the
RT   IL-1 signaling pathway.";
RL   J. Biol. Chem. 281:39891-39896(2006).
RN   [18]
RP   INTERACTION WITH RBCK1.
RX   PubMed=17449468; DOI=10.1074/jbc.M701913200;
RA   Tian Y., Zhang Y., Zhong B., Wang Y.Y., Diao F.C., Wang R.P.,
RA   Zhang M., Chen D.Y., Zhai Z.H., Shu H.B.;
RT   "RBCK1 negatively regulates tumor necrosis factor- and interleukin-1-
RT   triggered NF-kappaB activation by targeting TAB2/3 for degradation.";
RL   J. Biol. Chem. 282:16776-16782(2007).
RN   [19]
RP   UBIQUITINATION, INTERACTION WITH CYLD, AND DEUBIQUITINATION BY CYLD.
RX   PubMed=17548520; DOI=10.1084/jem.20062694;
RA   Reiley W.W., Jin W., Lee A.J., Wright A., Wu X., Tewalt E.F.,
RA   Leonard T.O., Norbury C.C., Fitzpatrick L., Zhang M., Sun S.C.;
RT   "Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-
RT   dependent kinase Tak1 and prevents abnormal T cell responses.";
RL   J. Exp. Med. 204:1475-1485(2007).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-439, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-439, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-389 AND SER-439, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-439 AND SER-455, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [25]
RP   INTERACTION WITH WDR34.
RX   PubMed=19521662; DOI=10.1007/s00018-009-0059-6;
RA   Gao D., Wang R., Li B., Yang Y., Zhai Z., Chen D.Y.;
RT   "WDR34 is a novel TAK1-associated suppressor of the IL-1R/TLR3/TLR4-
RT   induced NF-kappaB activation pathway.";
RL   Cell. Mol. Life Sci. 66:2573-2584(2009).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-389; SER-439 AND
RP   THR-444, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [27]
RP   INTERACTION WITH TAB2, AND PHOSPHORYLATION.
RX   PubMed=19675569; DOI=10.1038/nature08247;
RA   Xia Z.-P., Sun L., Chen X., Pineda G., Jiang X., Adhikari A., Zeng W.,
RA   Chen Z.J.;
RT   "Direct activation of protein kinases by unanchored polyubiquitin
RT   chains.";
RL   Nature 461:114-119(2009).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-389 AND SER-439, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 31-328 IN COMPLEX WITH TAB1
RP   AND ADENOSINE.
RX   PubMed=16289117; DOI=10.1016/j.jmb.2005.09.098;
RA   Brown K., Vial S.C., Dedi N., Long J.M., Dunster N.J.,
RA   Cheetham G.M.T.;
RT   "Structural basis for the interaction of TAK1 kinase with its
RT   activating protein TAB1.";
RL   J. Mol. Biol. 354:1013-1020(2005).
CC   -!- FUNCTION: Component of a protein kinase signal transduction
CC       cascade. Mediator of TRAF6 and TGF-beta signal transduction.
CC       Activates IKBKB and MAPK8 in response to TRAF6 signaling.
CC       Stimulates NF-kappa-B activation and the p38 MAPK pathway. In
CC       osmotic stress signaling, plays a major role in the activation of
CC       MAPK8/JNK, but not that of NF-kappa-B.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Activated by 'Lys-63'-linked
CC       polyubiquitination. Activated by proinflammatory cytokines and in
CC       response to physical and chemical stresses, including osmotic
CC       stress, oxidative stress, arsenic and ultraviolet light
CC       irradiation.
CC   -!- SUBUNIT: Binds both upstream activators and downstream substrates
CC       in multimolecular complexes. Interacts with TAB1/MAP3K7IP1 and
CC       TAB2/MAP3K7IP2. Identified in the TRIKA2 complex composed of
CC       MAP3K7, TAB1/MAP3K7IP1 and TAB2/MAP3K7IP2. Interacts with PPM1L.
CC       Interaction with PP2A and PPP6C leads to its repressed activity.
CC       Interacts with TRAF6 and TAB1/MAP3K7IP1; during IL-1 signaling.
CC       Interacts with TAOK1 and TAOK2; interaction with TAOK2 interferes
CC       with MAP3K7 interaction with IKKA, thus preventing NF-kappa-B
CC       activation. Interacts with WDR34 (via WD domains). Interacts with
CC       RBCK1. Interacts with CYLD.
CC   -!- INTERACTION:
CC       O95163:IKBKAP; NbExp=1; IntAct=EBI-358684, EBI-347559;
CC       Q99558:MAP3K14; NbExp=1; IntAct=EBI-358684, EBI-358011;
CC       Q9UQF2:MAPK8IP1; NbExp=1; IntAct=EBI-358684, EBI-78404;
CC       Q8N2H9:PELI3; NbExp=2; IntAct=EBI-358684, EBI-448457;
CC       P40763:STAT3; NbExp=1; IntAct=EBI-358684, EBI-518675;
CC       P42227:Stat3 (xeno); NbExp=1; IntAct=EBI-358684, EBI-602878;
CC       Q9NYJ8:TAB2; NbExp=1; IntAct=EBI-358684, EBI-358708;
CC       Q86Y07:VRK2; NbExp=2; IntAct=EBI-358684, EBI-1207615;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1B;
CC         IsoId=O43318-1; Sequence=Displayed;
CC       Name=1A;
CC         IsoId=O43318-2; Sequence=VSP_004886;
CC       Name=1C;
CC         IsoId=O43318-3; Sequence=VSP_004887, VSP_004888;
CC   -!- PTM: Association with TAB1/MAP3K7IP1 promotes autophosphorylation
CC       and subsequent activation. Association with TAB2/MAP3K7IP2, itself
CC       associated with free unanchored Lys-63 polyubiquitin chain,
CC       promotes autophosphorylation and subsequent activation of MAP3K7.
CC       Dephosphorylation at Thr-187 by PP2A and PPP6C leads to
CC       inactivation.
CC   -!- PTM: Ubiquitinated, leading to proteasomal degradation (By
CC       similarity). Requires 'Lys-63'-linked polyubiquitination for
CC       autophosphorylation and subsequent activation. 'Lys-63'-linked
CC       ubiquitination does not lead to proteasomal degradation.
CC       Deubiquitinated by CYLD, a protease that selectively cleaves 'Lys-
CC       63'-linked ubiquitin chains. Deubiquitinated by Y.enterocolitica
CC       YopP.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase kinase subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB009357; BAA25026.1; -; mRNA.
DR   EMBL; AB009356; BAA25025.1; -; mRNA.
DR   EMBL; AB009358; BAA25027.2; -; mRNA.
DR   EMBL; DQ314875; ABC40734.1; -; Genomic_DNA.
DR   EMBL; AK315774; BAG38124.1; -; mRNA.
DR   EMBL; AL121964; CAI19610.1; -; Genomic_DNA.
DR   EMBL; AL121837; CAI19610.1; JOINED; Genomic_DNA.
DR   EMBL; AL121964; CAI19611.1; -; Genomic_DNA.
DR   EMBL; AL121837; CAI19611.1; JOINED; Genomic_DNA.
DR   EMBL; AL121964; CAI19612.1; -; Genomic_DNA.
DR   EMBL; AL121837; CAI19612.1; JOINED; Genomic_DNA.
DR   EMBL; AL121837; CAI23530.1; -; Genomic_DNA.
DR   EMBL; AL121964; CAI23530.1; JOINED; Genomic_DNA.
DR   EMBL; AL121837; CAI23532.1; -; Genomic_DNA.
DR   EMBL; AL121964; CAI23532.1; JOINED; Genomic_DNA.
DR   EMBL; AL121837; CAI23533.1; -; Genomic_DNA.
DR   EMBL; AL121964; CAI23533.1; JOINED; Genomic_DNA.
DR   EMBL; CH471051; EAW48525.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48526.1; -; Genomic_DNA.
DR   EMBL; BC017715; AAH17715.1; -; mRNA.
DR   IPI; IPI00218566; -.
DR   IPI; IPI00218567; -.
DR   IPI; IPI00295738; -.
DR   PIR; JC5955; JC5955.
DR   PIR; JC5956; JC5956.
DR   RefSeq; NP_003179.1; -.
DR   RefSeq; NP_663304.1; -.
DR   RefSeq; NP_663305.1; -.
DR   RefSeq; NP_663306.1; -.
DR   UniGene; Hs.644143; -.
DR   PDB; 2EVA; X-ray; 2.00 A; A=31-303.
DR   PDBsum; 2EVA; -.
DR   ProteinModelPortal; O43318; -.
DR   DIP; DIP-27523N; -.
DR   IntAct; O43318; 115.
DR   MINT; MINT-88554; -.
DR   STRING; O43318; -.
DR   PhosphoSite; O43318; -.
DR   PRIDE; O43318; -.
DR   Ensembl; ENST00000369329; ENSP00000358335; ENSG00000135341.
DR   GeneID; 6885; -.
DR   KEGG; hsa:6885; -.
DR   UCSC; uc003pnz.1; human.
DR   UCSC; uc003pob.1; human.
DR   CTD; 6885; -.
DR   GeneCards; GC06M091282; -.
DR   H-InvDB; HIX0006075; -.
DR   HGNC; HGNC:6859; MAP3K7.
DR   HPA; HPA007633; -.
DR   MIM; 602614; gene.
DR   PharmGKB; PA30603; -.
DR   eggNOG; prNOG18976; -.
DR   HOGENOM; HBG716529; -.
DR   HOVERGEN; HBG003485; -.
DR   InParanoid; O43318; -.
DR   OMA; GSFMDIT; -.
DR   OrthoDB; EOG9N337N; -.
DR   PhylomeDB; O43318; -.
DR   BRENDA; 2.7.11.25; 247.
DR   Pathway_Interaction_DB; bcr_5pathway; BCR signaling pathway.
DR   Pathway_Interaction_DB; bmppathway; BMP receptor signaling.
DR   Pathway_Interaction_DB; ephrinbrevpathway; Ephrin B reverse signaling.
DR   Pathway_Interaction_DB; faspathway; FAS signaling pathway (CD95).
DR   Pathway_Interaction_DB; il1pathway; IL1-mediated signaling events.
DR   Pathway_Interaction_DB; tcrjnkpathway; JNK signaling in the CD4+ TCR pathway.
DR   Pathway_Interaction_DB; wnt_calcium_pathway; Noncanonical Wnt signaling pathway.
DR   Pathway_Interaction_DB; p38_mkk3_6pathway; p38 MAPK signaling pathway.
DR   Pathway_Interaction_DB; ps1pathway; Presenilin action in Notch and Wnt signaling.
DR   Pathway_Interaction_DB; tgfbrpathway; TGF-beta receptor signaling.
DR   Pathway_Interaction_DB; tnfpathway; TNF receptor signaling pathway.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   NextBio; 26899; -.
DR   ArrayExpress; O43318; -.
DR   Bgee; O43318; -.
DR   CleanEx; HS_MAP3K7; -.
DR   Genevestigator; O43318; -.
DR   GermOnline; ENSG00000135341; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0010008; C:endosome membrane; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; IDA:UniProtKB.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0007250; P:activation of NF-kappaB-inducing kinase act...; IMP:UniProtKB.
DR   GO; GO:0007252; P:I-kappaB phosphorylation; IDA:UniProtKB.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-k...; IMP:UniProtKB.
DR   GO; GO:0032743; P:positive regulation of interleukin-2 produc...; IMP:UniProtKB.
DR   GO; GO:0043507; P:positive regulation of JUN kinase activity; IDA:UniProtKB.
DR   GO; GO:0050870; P:positive regulation of T cell activation; IC:UniProtKB.
DR   GO; GO:0002726; P:positive regulation of T cell cytokine prod...; IMP:UniProtKB.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; NAS:UniProtKB.
DR   GO; GO:0007179; P:transforming growth factor beta receptor si...; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR015786; MAPKKK-related.
DR   InterPro; IPR017421; MAPKKK7.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   PANTHER; PTHR23257:SF92; MAPKKK-related; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PIRSF; PIRSF038168; MAPKKK7; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Kinase; Magnesium; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Serine/threonine-protein kinase; Transferase; Ubl conjugation.
FT   CHAIN         1    606       Mitogen-activated protein kinase kinase
FT                                kinase 7.
FT                                /FTId=PRO_0000086252.
FT   DOMAIN       36    291       Protein kinase.
FT   NP_BIND      42     50       ATP (By similarity).
FT   COMPBIAS      8     14       Poly-Ser.
FT   ACT_SITE    156    156       Proton acceptor (By similarity).
FT   BINDING      63     63       ATP.
FT   MOD_RES     184    184       Phosphothreonine; by autocatalysis
FT                                (Probable).
FT   MOD_RES     187    187       Phosphothreonine; by autocatalysis.
FT   MOD_RES     192    192       Phosphoserine; by autocatalysis
FT                                (Probable).
FT   MOD_RES     389    389       Phosphoserine.
FT   MOD_RES     439    439       Phosphoserine.
FT   MOD_RES     444    444       Phosphothreonine.
FT   MOD_RES     455    455       Phosphoserine.
FT   VAR_SEQ     404    430       Missing (in isoform 1A).
FT                                /FTId=VSP_004886.
FT   VAR_SEQ     509    518       PLAPCPNSKE -> ARTSCRTGPG (in isoform 1C).
FT                                /FTId=VSP_004887.
FT   VAR_SEQ     519    606       Missing (in isoform 1C).
FT                                /FTId=VSP_004888.
FT   MUTAGEN      63     63       K->W: Loss of kinase activity.
FT   HELIX        33     35
FT   STRAND       36     43
FT   STRAND       46     55
FT   STRAND       58     64
FT   HELIX        70     83
FT   STRAND       92     95
FT   TURN         97    100
FT   STRAND      101    105
FT   HELIX       112    117
FT   STRAND      119    123
FT   HELIX       127    145
FT   STRAND      148    150
FT   HELIX       159    161
FT   STRAND      162    165
FT   TURN        166    169
FT   STRAND      170    173
FT   HELIX       198    201
FT   HELIX       209    224
FT   TURN        228    232
FT   HELIX       236    244
FT   HELIX       257    266
FT   HELIX       271    273
FT   HELIX       277    287
FT   HELIX       288    290
FT   STRAND      312    314
SQ   SEQUENCE   606 AA;  67196 MW;  3D8F8147CD174013 CRC64;
     MSTASAASSS SSSSAGEMIE APSQVLNFEE IDYKEIEVEE VVGRGAFGVV CKAKWRAKDV
     AIKQIESESE RKAFIVELRQ LSRVNHPNIV KLYGACLNPV CLVMEYAEGG SLYNVLHGAE
     PLPYYTAAHA MSWCLQCSQG VAYLHSMQPK ALIHRDLKPP NLLLVAGGTV LKICDFGTAC
     DIQTHMTNNK GSAAWMAPEV FEGSNYSEKC DVFSWGIILW EVITRRKPFD EIGGPAFRIM
     WAVHNGTRPP LIKNLPKPIE SLMTRCWSKD PSQRPSMEEI VKIMTHLMRY FPGADEPLQY
     PCQYSDEGQS NSATSTGSFM DIASTNTSNK SDTNMEQVPA TNDTIKRLES KLLKNQAKQQ
     SESGRLSLGA SRGSSVESLP PTSEGKRMSA DMSEIEARIA ATTAYSKPKR GHRKTASFGN
     ILDVPEIVIS GNGQPRRRSI QDLTVTGTEP GQVSSRSSSP SVRMITTSGP TSEKPTRSHP
     WTPDDSTDTN GSDNSIPMAY LTLDHQLQPL APCPNSKESM AVFEQHCKMA QEYMKVQTEI
     ALLLQRKQEL VAELDQDEKD QQNTSRLVQE HKKLLDENKS LSTYYQQCKK QLEVIRSQQQ
     KRQGTS
//
